摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,5,5,8,8-pentamethyl-5,6,7,8,-tetrahydro-2-naphthalenyl)-1-cyclohexene-1-carboxylic acid ethyl ester | 179538-88-6

中文名称
——
中文别名
——
英文名称
2-(3,5,5,8,8-pentamethyl-5,6,7,8,-tetrahydro-2-naphthalenyl)-1-cyclohexene-1-carboxylic acid ethyl ester
英文别名
ethyl 2-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)cyclohexene-1-carboxylate
2-(3,5,5,8,8-pentamethyl-5,6,7,8,-tetrahydro-2-naphthalenyl)-1-cyclohexene-1-carboxylic acid ethyl ester化学式
CAS
179538-88-6
化学式
C24H34O2
mdl
——
分子量
354.533
InChiKey
CQWLTISSWVXUMC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.1
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Restricted 9-cis retinoids
    申请人:American Cyanamid Company
    公开号:US05968908A1
    公开(公告)日:1999-10-19
    The invention is novel analogs of 9-cis-retinoic acid which are useful for the treatment and prevention of coronary artery disease and to protect against premature atherosclerosis by increasing HDL levels. The invention includes processes for preparing the novel 9-cis-retinoic acid analogs.
    该发明涉及一种新型9-顺-视黄酸类似物,可用于治疗和预防冠状动脉疾病,并通过增加高密度脂蛋白水平来保护免受早期动脉粥样硬化的影响。该发明还包括制备这种新型9-顺-视黄酸类似物的方法。
  • Restricted 9-cis-retinoids
    申请人:American Cyanamid Company
    公开号:EP0718285A2
    公开(公告)日:1996-06-26
    The invention is novel analogs of 9-cis-retinoic acid which are useful for the treatment and prevention of coronary artery disease and to protect against premature atherosclerosis by increasing HDL levels. The invention includes processes for preparing the novel 9-cis-retinoic acid analogs.
    本发明是新型 9-顺式维甲酸类似物,可用于治疗和预防冠状动脉疾病,并通过提高高密度脂蛋白水平防止动脉粥样硬化过早发生。本发明包括制备新型 9-顺式维甲酸类似物的工艺。
  • Restricted 9-cis retenoids
    申请人:American Cyanamid Company
    公开号:EP0997455A1
    公开(公告)日:2000-05-03
    The invention is novel analogs of 9-cis-retinoic acid which are useful for the treatment and prevention of coronary artery disease and to protect against premature atherosclerosis by increasing HDL levels. The invention includes processes for preparing the novel 9-cis-retinoic acid analogs.
    本发明是新型 9-顺式维甲酸类似物,可用于治疗和预防冠状动脉疾病,并通过提高高密度脂蛋白水平防止动脉粥样硬化过早发生。本发明包括制备新型 9-顺式维甲酸类似物的工艺。
  • US5968908A
    申请人:——
    公开号:US5968908A
    公开(公告)日:1999-10-19
  • A Novel Synthesis of 9,13-dicis Double Bonds Locked Retinoids
    作者:Feng-Ling Qing、Xiang-Jun Yue
    DOI:10.1016/s0040-4039(97)10246-5
    日期:1997.11
    Synthesis of two retinoids in which the 9,13-dicis double bonds were locked in cycloalkene or thiophene was described. The key step was carbonylation of vinyl bromide 9 and 16 with carbon monoxide in the presence of Pd(PPh3)(4). (C) 1997 Elsevier Science Ltd.
查看更多